Home > Expanded Access > Lorlatinib - PF-06463922

Pfizer

Lorlatinib - PF-06463922

Brief Summary: 
Information relating to requesting compassionate access for this investigational drug can be found at the following link: http://www.pfizer.com/research/compassionate_use
Available
EA Type
Individual Patients

Drug: Lorlatinib

Eligibility Criteria: 

Inclusion Criteria:

- Adult, Senior

Exclusion Criteria:

-

Eligibility Gender: 
All
Eligibility Age: 
Minimum: 18 Years
Contacts: 

Pfizer CAReS
1-800-718-1021
PfizerCAReS@pfizer.com

EA Number: 
Disclaimer:
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.